Abstract
EE186 A Comparative Cost Analysis between Dalbavancin, Oritavancin and Delafloxacin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Spain
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have